ClinicalTrials.gg
RecruitingNCT05978336Updated Sep 4, 2026

SuPA Mobility: Supporting Physical Activity for Mobility in Mobility-Limited Older Adults

An interventional study of Health Coaching Program and Health Education Program in Limitation, Mobility and Older Adults, sponsored by University of British Columbia. Recruiting at 1 site in Canada. Open to participants aged 70 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-09-04.

Sponsored by University of British Columbia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2023; still recruiting 3 years 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
290
Allocation
Randomized
Ages
70 Years to 89 Years
Sex
All
01

Study summary

The goal of this randomized controlled trial is to investigate the effectiveness of a health-coaching intervention to improve physical activity in older adults with limited mobility when compared to a control, health education group.

Read the detailed description

A total of 290 older adults with limited mobility will be randomized to either a 26-week health coaching program or health education program. Outcomes will be assessed at baseline, 13-weeks, 26-weeks (end of intervention), and 52 week (6-month follow-up period).

02

Conditions studied

  • Limitation, Mobility
  • Older Adults

Keywords

  • physical activity
  • health coaching
  • exercise
  • limited mobility
03

In context

Mobility Limitation

381 studies on the registry are indexed under Mobility Limitation; 108 are open to participants now.

This study's planned enrollment of 290 is above the median of 46 across 316 interventional studies indexed under Mobility Limitation.

Browse Mobility Limitation studies →

Lead sponsor

University of British Columbia is the lead sponsor of 1,339 studies on the registry; 259 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
70 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • scored ≤ 9/12 on the SPPB
  • are able to complete the 400-m walk in ≤ 15 minutes without sitting or physical assistance from another person or walker (use of cane is acceptable)
  • scored 22/30 or higher on the (MMSE)
  • have no significant functional impairment as indicated by a score of 6/8 or higher on the Lawton and Brody Instrumental Activities of Daily Living Scale
  • are able to safely engage in MVPA as indicated by the PAR-Q+ and by the family or study physician as necessary
  • are community-dwelling
  • are able to provide written .

Exclusion criteria

Exclusion Criteria:

  • are diagnosed with dementia or stroke
  • self-report engaging in MVPA ≥ 10 minutes per week in the prior 3 months
  • are unable to understand, speak, and read English proficiently
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
290 participants (estimated)

Study arms

  • Experimental
    Health Coaching (HC)

    The health coaching program will be delivered by trained and certified kinesiologists utilizing Brief Action Planning (BAP) principals. The BAP behavior change approach utilizes the following 4 techniques: 1) goal-setting; 2 )action planning; 3) self-monitoring; and 4) feedback. Participants will utilize daily physical activity diaries to enable self-monitoring, and BAP coaches will provide feedback on progress toward individualized physical activity goals.

    Behavioral: Health Coaching Program

  • Active comparator
    Health Education Program (ED)

    This program is an attention control group, which consists of general health education. Education sessions will be delivered either by zoom or in person. The education sessions will cover the following topics: 1) falls prevention; 2) sleep; 3) healthy eating; 4) cognitive health; and 5) mental and emotional health.

    Behavioral: Health Education Program

Interventions

  • BehavioralHealth Coaching Program

    The HC program will be delivered over 26-weeks. Participants will have an initial hour-long HC session where the BAP coach will conduct a brief physical assessment and work with the participant to establish their physical activity goals and develop a plan. After the initial consult, coaches will conduct 8 x 20-minute phone calls with participants over the 26-week trial decreasing from bi-weekly phone calls in weeks 1-12 to monthly phone calls in weeks 13-26. Participants in the HC group will have an overall goal of increasing their weekly participation in moderate to vigorous physical activity by 50 minutes, via 5-, 7-, or 10-minute bouts of progressive exercises, at a rate of perceived exertion range of 13-14 ("somewhat hard") by week 16. Participants will have access to specific exercise sessions made available by YouTube and/or hardcopy manuals created by the research team.

    Also known as: HC

  • BehavioralHealth Education Program

    Participants will begin with a one-hour, group-based, interactive education session on falls prevention delivered either in-person or by Zoom. Following the initial education session, ED participants will receive additional group education sessions (in-person or by Zoom) with the same duration and schedule as the HC program covering a variety of healthy aging topics.

    Also known as: ED

06

What researchers measure

Primary outcomes

  1. Mobility

    Measured by the Short Physical Performance Battery (SPPB)

    Time frame: Baseline, 13-weeks, 26-weeks, 52-weeks

Secondary outcomes

  1. Physical activity

    Time spent moderate to vigorous physical activity and sedentary time measured by accelerometer.

    Time frame: Baseline, 13-weeks, 26-weeks, 52-weeks

  2. Self reported physical activity

    Measured by the Community Health Activities Model Program for Seniors (CHAMPS) Physical Activity Questionnaire for Older Adults.

    Time frame: Baseline, 13-weeks, 26-weeks, 39-weeks, 52-weeks

  3. Gait speed

    Measured during the 4-m walk

    Time frame: Baseline, 13- weeks, 26-weeks, 52-weeks

  4. Capacity to complete the 400-m walk in ≤ 15 minutes

    measured as yes or no

    Time frame: Baseline, 13- weeks, 26-weeks, 52-weeks

  5. Cognitive function

    Measured with the NIH Toolbox and standard neuropsychological assessments

    Time frame: Baseline, 13-weeks, 26-weeks, 52-weeks

  6. Community mobility

    Measured with the Life Space Questionnaire

    Time frame: Baseline, 13-weeks, 26-weeks, 39-weeks, 52-weeks

  7. Functional mobility

    Measured as the time to complete the Timed Up-and-Go (TUG)

    Time frame: Baseline, 13-weeks, 26-weeks, 52-weeks

  8. Fatigue

    Measured by the 9-item Fatigue Severity Scale (FSS) scored from 9 to 63, with higher scores indicating more severe fatigue

    Time frame: Baseline, 13-weeks, 26-weeks, 39-weeks, 52-weeks

  9. Lower extremity strength

    Measured with strain gauge (kilograms) on dominant quadriceps

    Time frame: Baseline, 13- weeks, 26-weeks, 52-weeks

  10. Grip strength

    Measured with digital Jamar isometric dynamometer (Newtons)

    Time frame: Baseline, 13-weeks, 26-weeks, 52-weeks

  11. Mood

    Measured by the Centre for Epidemiological Studies Depression Scale (CES-D)

    Time frame: Baseline, 13-weeks, 26-weeks, 39-weeks, 52-weeks

  12. Health-related quality of life

    Measured with questionnaire EuroQol (EQ-5D-5L)

    Time frame: Baseline, 13-weeks, 26-weeks, 39-weeks, 52-weeks

  13. Sleep

    Measured with 19-item Pittsburgh Sleep Quality Index

    Time frame: Baseline, 13-weeks, 26-weeks, 39-weeks, 52-weeks

  14. Sleep

    Measured by accelerometer

    Time frame: Baseline, 13-weeks, 26-weeks, 52-weeks

  15. Falls

    Assessed with monthly calendar and questionnaire

    Time frame: Baseline, monthly

  16. Health resource utilization

    Assessed with a questionnaire

    Time frame: Baseline, 13-weeks, 26-weeks, 39-weeks, 52-weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Rice J, Li LC, Davis JC, Pahor M, Madden K, Wei N, Wong H, Skelton DA, McCormick S, Falck RS, Barha CK, Rhodes RE, Loomba S, Sadatsafavi M, Liu-Ambrose T. Supporting physical activity for mobility in older adults with mobility limitations (SuPA Mobility): study protocol for a randomized controlled trial. Trials. 2023 Nov 28;24(1):769. doi: 10.1186/s13063-023-07798-9. PubMed 38017467 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05978336
Collaborators
Canadian Institutes of Health Research (CIHR)
Responsible party
Teresa Liu-Ambrose (Professor, University of British Columbia) — Principal investigator
First posted
Aug 7, 2023
Start date
Sep 5, 2023
Primary completion
Jun 30, 2027 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
Sep 4, 2026

Study contacts

Nathan Wei, B.Sc.
Contact
nathan.wei@ubc.ca
604-875-4111 ext. 69056
Teresa Liu-Ambrose, PhD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion